EULAR 2021: Expert Insights on Axial Spondyloarthritis and Axial Psoriatic Arthritis*

Most DMARDs, including methotrexate, biologics, and JAK inhibitors, can be continued when the BNT162b2 mRNA COVID-19 vaccine is given.

In this real-world cohort, patients with axial spondyloarthritis demonstrated higher rates of uveitis and IBD, reported greater overall and spine pain vs patients with axial psoriatic arthritis.

MRI criteria including bone marrow edema in ≥4 vertebral corners (or fewer if other lesions present) found to be consistent with rheumatologic diagnosis.

SPARCC method with transitional slice and subsequent 4 slices optimal to evaluate for lesions in SIJ in patients with axSpA.

Although disease activity improved with ixekizumab treatment regardless of sex, time to improvement and peak response was longer for females vs males.

Even without flare, withdrawal of CZP associated with increased ASDAS, CRP, BASDAI, and fecal calprotectin.

Across SpA-specific assessments, patients with primary or secondary fibromyalgia demonstrated higher PRO scores vs patients with axSpA/PsA alone.

CSI ≥40 significantly associated with higher ASQoL score, higher ASDAS score, and female sex.